跳至主要内容
临床试验/NCT01652755
NCT01652755Unknown不适用

Use of Cystatin C in Predicting AKI in Patients Undergone Cardiopulmonary Bypass Surgery

Jinhua Central Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年4月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1

研究概览

简要总结

To evaluate the utility of plasma cystatin C(pCysC) as a predictive and diagnostic marker of acute kidney injury(AKI) in patients undergone cardiopulmonary bypass surgery.

详细描述

This is a prospective AKI observational study in patients undergone cardiopulmonary bypass surgery. pCysC and plasma creatine will be measured at entry to ICU.AKI was defined as 50% increase in plasma creatine above baseline.The predictive and diagnostic performance of pCysC will be assessed from area under receiver operator characteristic curve(AUC) and odds ratio(OR).

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with CPB and admitted to ICU

排除标准

  • patients with the age >80 or <18 years
  • with preexisting renal dysfunction

研究者

发起方
Jinhua Central Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hongying Ni

Department vice director

Jinhua Central Hospital

研究点 (1)

Loading locations...

相似试验